# Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience

**Authors:** Ningning Yan, Sanxing Guo, Siyuan Huang, Huixian Zhang, Xingya Li

PMC · DOI: 10.3389/fonc.2024.1412472 · Frontiers in Oncology · 2024-06-03

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}
- **Chemicals:** furmonertinib (MESH:C000705711)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11181905/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11181905/full.md

---
Source: https://tomesphere.com/paper/PMC11181905